Elanco Animal Health (ELAN) Revenue (2017 - 2026)

Elanco Animal Health has disclosed Revenue across 10 years of filings, most recently posting $1.4 billion for Q1 2026.

• Revenue for Q1 2026 came in at $1.4 billion, up 14.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 10.53% YoY), and the FY2025 annual result was $4.7 billion, up 6.22% from the prior year.
• Revenue came in at $1.4 billion for Q1 2026 at Elanco Animal Health, up from $1.1 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.4 billion in Q1 2026 to a low of $985.0 million in Q4 2022.
• The 5-year median for Revenue is $1.1 billion (2025), against an average of $1.1 billion.
• Across the five-year window, Revenue retreated 11.42% in 2022 and climbed 14.92% in 2026, its largest moves.
• Elanco Animal Health's Revenue stood at $985.0 million in 2022, then rose by 5.08% to $1.0 billion in 2023, then decreased by 1.45% to $1.0 billion in 2024, then climbed by 12.16% to $1.1 billion in 2025, then climbed by 19.84% to $1.4 billion in 2026.
• The last three Revenue figures came in at $1.4 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.